THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness

Clinical trial NCT07578298 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07578298
Sponsor: Menzies School of Health Research
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)Respiratory Infection Virus

Start date: 2026-05-15
Primary completion: 2030-07-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.